The lawsuit brought against the Indian Government by Swiss pharmaceutical company Novartis began in New Delhi on September 11. This new offensive follows the failure of a previous court case six years ago. Novartis is contesting part of Indian law on patents that enables Indian manufacturers to produce affordable generic drugs. Learn more.